Product Liability Lawyer Blog

January 15, 2014

Transvaginal Mesh Injuries Most Commonly Reported

Women who suffer from transvaginal mesh injuries may be embarrassed to discuss their condition with friends, loved ones, or even a medical professional. Victims may even postpone going to the doctor because they are waiting for symptoms to improve. However, if you or someone you love has suffered a transvaginal mesh injury, you know how severe the consequences can be. You also know that sustained injuries can significantly impact the quality of life for victims. Transvaginal mesh injuries are very severe and hundreds of thousands of women have suffered after having a vaginal mesh implant.

Once considered awkward and personal problems, these injuries are now becoming increasingly common medical conditions for women who have had a vaginal mesh implant. Our transvaginal mesh injury attorneys are experienced in representing women who have suffered pain, complications, and dangerous injuries resulting from transvaginal mesh. For victims the consequences of a transvaginal mesh injury are not only painful and life-altering, they can also be deadly.
Continue reading

January 14, 2014

Janssen Appealing Topamax Ruling for Plaintiffs

by Jeffrey S. Glassman

Plaintiffs suffering from Topamax birth defects received good news when two recent cases resulted in combined compensation of $15 million for victims. In one of the two recent cases, the plaintiff was awarded almost $11 million in damages from Janssen Pharmaceuticals, the manufacturer of Topamax and a division of Johnson & Johnson. In the second case, $4.02 million was awarded to a family whose child was born with a cleft palate after his mother took Topamax while pregnant.

The Topamax verdicts were a positive sign for plaintiffs because large verdicts for victims can sometimes make drug companies more eager to offer fair settlements to individuals whose defective drug cases are still pending. However, in this case, Janssen Pharmaceuticals does not appear to have given in yet to accepting that it is likely to be found liable for injuries in courts. Instead, Janssen Pharmaceuticals has announced the company’s intent to appeal the verdicts against it. Our Boston defective drug lawyers know that the outcome of the appeals could shape how future Topamax claims are resolved since a loss in appellate court could make Janssen much more likely to move forward with settlement talks.
Continue reading

January 10, 2014

Transvaginal Mesh Lawsuits Scheduled in 2014

by Jeffrey S. Glassman

As the New Year approaches, many women currently suffering from transvaginal mesh complications will be closely watching the TVM litigation that is expected to occur in 2014. This year is likely to be an important one in which many TVM cases are resolved and in which the medical device manufacturers who sold TVM products may move forward with settling claims.

Ourtransvaginal mesh attorneys know that there are going to be many important milestones in TVM litigation in the upcoming year since there are several different bellwether trials that will occur. There are currently more than 40,000 lawsuits pending related to TVM products and each of these thousands of women could be affected by the outcome of trials beginning as early as January 10, 2014.
Continue reading

January 7, 2014

Stryker Settles Claims Related to Defective Hip Replacements

by Jeffrey S. Glassman

Stryker Corp. is the manufacturer of hip replacement and resurfacing products including the Stryker Rejuvenate and the Stryker ABG II hip implants. The orthopaedic device company recalled both of these products in 2012 amid complaints that the devices had a high failure rate and that patients were suffering serious injuries as a result of product defects.

Unfortunately, before the Stryker products were recalled, our hip implant lawyers know that an estimated 20,000 Americans already had either a Rejuvenate or ABG II medical device used in their hip replacement procedure. Many of the patients who used these Stryker hip replacement devices have now begun to experience serious complications and, as a result, have filed lawsuits against the Michigan-based manufacturer. Several of these claims have now settled and many more cases could soon be resolved with plaintiffs being offered compensation out of court for their losses.
Continue reading

January 5, 2014

Plaintiffs Seek Creation of Seventh MDL For Vaginal Mesh Complications

by Jeffrey S. Glassman

Throughout the federal court system in the United States, there are currently more than 35,000 lawsuits pending related to complications associated with transvaginal mesh products. Transvaginal mesh, or TVM, was marketed as an alternative to traditional surgical procedures to treat pelvic organ prolapse (POP) or stress urinary incontinence (SUI). Unfortunately, thousands of women who had vaginal mesh surgically implanted began to experience erosion of the mesh, resulting in significant pain and serious complications, including perforation of the pelvic organs and recurrent POP.

Women who have experienced these side effects have filed lawsuits against vaginal mesh manufacturers seeking compensation for the tremendous losses they have faced. Those harmed by defective medical devices should be compensated for any medical costs that they incur to treat their injuries, such as surgical removal of the mesh. Individuals harmed by TVM products are also entitled to compensation for lost income, pain and suffering and emotional distress associated with injuries caused by the defective mesh products. Taking legal action to recover compensation for these losses is necessary, and the more than 35,000 lawsuits show that many women are exercising their legal rights.

When so many cases are filed by injured victims, Boston transvaginal mesh lawyers know that the formation of multi-district litigations is a common and effective way to resolve patient complaints. There are currently six MDLs pending and a group of plaintiffs is now calling for the creating of a seventh.
Continue reading

January 1, 2014

Stem Cell Research Reduces Need for Knee Replacement Devices

by Jeffrey S. Glassman

Americans routinely suffer from cartilage damage, either from a single injury or because of age, requiring them to turn to dangerous alternatives, including Stryker knee replacements. Knee implants manufactured by Stryker have been linked to serious injury caused by the dangerous medical implants.

According to reports, researchers at UCLA have published the first study to track origin cells and the early development of articular cartilage. The research has led to a kind of “roadmap” for new treatments and therapies to repair cartilage damage caused by osteoarthritis. Advocates for the new therapy claim it can repair cartilage damage so that patients do not have to turn to dangerous medical devices, including Stryker products. Our Stryker hip attorneys are experienced in protecting victims and preventing future injuries. We are experienced in cases involving defective medical devices and can effectively protect your rights if you or someone you love has suffered medical malpractice as a result of a defective medical device.

Stryker has been the subject of litigation for injuries called by the defective knee replacements. In April 2013, a recall of the product was issued to prevent additional injuries caused by poorly-fitting, loose knee implants. The Stryker knee system is a brand developed by Stryker Orthopedics and approved by the FDA in 2005. Older models of knee implants used a single hinge, where the newer Stryker implant model pivoted to maintain a single radius design.
Continue reading

December 31, 2013

Tips for Determining If You Have a Topamax Claim

by Jeffrey S. Glassman

Johnson & Johnson pharmaceuticals has been in the news recently, as the company’s subsidiaries have resolved pending claims against them… and not in the company’s favor. One subsidiary, Ethicon, may pay as much as $4 billion in damages to settle lawsuits from defective hip implants. Another, Janssen Pharmaceuticals, has had two multi-million jury verdicts against the company based on Topamax birth defects, and will be required to provide compensation of around $11 million to one family and just over $4 million to another.

For those who were taking Topamax during pregnancy and whose child was born with a birth injury such as a cleft palate, a heart or lung defect, a penile defect called hypospadias, malformed limbs or spina bifida, it is important to have claims evaluated to determine if you too have a legal right to damages. Our personal injury lawyers in Massachusetts can conduct case evaluations for families who may be affected by Topamax.
Continue reading

December 26, 2013

Transvaginal Mesh Injuries Tracked by FDA Since 2005

by Jeffrey S. Glassman

As a patient, you trust that your doctor is well-informed of medical advancements, including developments and products that could be dangerous to your health. Patients who have been a victim of transvaginal mesh injuries may be surprised to discover that doctors were informed of the dangers in 2008. According to a public health notification published in 2008, there are serious complications associated with transvaginal placement of surgical mess to repair pelvic organ prolapse and to treat urinary incontinence.

In an FDA warning issued on October 20, 2008, physicians were warned that complications associated with transvaginal mesh can have adverse effects and serious health consequences. Despite this initial warning and continued reports of injuries, the product has still not been recalled. Our medical malpractice attorneys in Massachusetts continue to advocate for the victims of Transvaginal Mesh injuries. We are dedicated to keeping our clients, the medical community, and patients aware of the dangerous of medical devices to protect future injuries.
Continue reading

December 24, 2013

Topamax Birth Defect Lawsuits and Cleft Palate Treatment Costs

by Jeffrey S. Glassman

The anti-seizure medication Topamax is one of the top selling medications in its class, and by 2008, had U.S. sales in excess of $10 billion. The medication, however, may be very dangerous for pregnant women and infants. Medical studies have shown that the risk of a child being born with a cleft palette increases drastically if a baby is exposed to Topamax in the womb during fetal development. The FDA also recognizes the link between Topamax and birth defects and, on March 4, 2011, informed the public of data showing that Topamax was linked to cleft palates.

topamax plaintiff lawyers know that a cleft palate can have serious implications for a child. A cleft palate occurs when the baby’s natural body structures do not fuse correctly during gestation, resulting in a fissure or opening in the lip and palate. Children with a cleft palate can experience speech difficulties; hearing loss; dental problems; nasal problems and difficulty feeding. Multiple surgeries are often required to correct the cleft, which can be very costly. As a parent of a child with a cleft palate, it is important to take action to get money for cleft palate treatment. Many parents already have, and hundreds of Topamax lawsuits are pending.
Continue reading

December 22, 2013

FDA Expands Control Over Compounding Pharmacies

by Jeffrey S. Glassman

In previous posts, we have discussed the dangerous nature of compounding pharmacies, including the lack of federal regulation, the risk of counterfeit, and the general threat to consumers in Massachusetts and nationwide. Last year a meningitis outbreak and other events involving compounded drugs lead to serious infection and in many cases resulted in death. Since the outbreak, Congress has been working to pass comprehensive legislation to give authority to the FDA to properly regulate compounded drugs. According to an official statement from the FDA, a new law may help to properly regulate the industry and keep consumers safe.

The risk of dangerous or defective drugs produced by compounding pharmacies is significant. Our Boston injury attorneys are dedicated to protecting the rights of individual clients as well as consumers nationwide. We will take necessary action against compounding pharmacies and are committed to staying abreast of legal developments that may have a positive impact on the health of our nation. The Drug Quality and Security Act is a positive step in this direction.
Continue reading